Paul Hastings Advises TD Cowen and Evercore ISI in vTv Therapeutics’ PIPE Financing

Paul Hastings LLP advised TD Cowen and Evercore ISI as placement agents in vTv Therapeutics Inc.’s (Nasdaq: VTVT) $80 million private placement. The PIPE financing is expected to close on or around September 3, 2025, subject to customary closing conditions.

vTv Therapeutics is a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of Type 1 diabetes.

Equity Capital Markets and Corporate Life Sciences chair Seo Salimi and partner Will Magioncalda led the Paul Hastings team, which included associate Chris Guerin.

More details can be found here.

About Paul Hastings

With widely recognized elite teams across 17 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers and corporations.